Steth Pharmaceuticals Llp - Company overview

Steth Pharmaceuticals Llp is an MCA-registered Indian LLP: a Limited Liability Partnership (LLPIN/FCRN AAG-0212). Business overview includes…

2016-03-22 Bangalore South, Karnataka Active LLP
View plans
SP Steth Pharmaceuticals Llp
Complete Company Report + Documents
  • MCA filings & documents
  • P&L, balance sheet, cash flow & ratios
  • Year-wise charts & analysis
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
MCA Documents Access
  • Public filings
  • Bulk ZIP download
  • Dashboard access (1 year)
₹300 ₹149 50% off New user
Or enjoy up to 50% off with credits View credit packages

Key Metrics

AUTHORISED CAPITAL
1.00 Lakh
PAID-UP CAPITAL
-
COMPANY AGE
10 Years 1 Months
since 2016-03-22
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-03-31
OPEN CHARGES
-
-
SATISFIED CHARGES
-
-
REVENUE
PROFIT / LOSS
EBITDA
NET WORTH
TOTAL ASSETS
TOTAL MONEY RAISED
ACTIVE GST
1
Updated: 2023-12-31 07:23:43

About Steth Pharmaceuticals Llp

Steth Pharmaceuticals Llp is an MCA-registered Indian LLP: a Limited Liability Partnership (LLPIN/FCRN AAG-0212). Business overview includes Pharma (Drug Formulation & Development), incorporated on March 22, 2016 (10+ years old), headquartered in Bangalore South, Karnataka, India. The LLP is currently Active. It has 2 active partners.

Drug Formulation & Development
  • Location No.2397/15, 18Th Main,, Bangalore South, Karnataka - 560078
CIN / LLPINAAG-0212
Company No.-
ClassificationLimited Liability Partnership
Incorporation Date2016-03-22
Date of AGM2025-03-31
Date of Balance Sheet2025-03-31
Listing Status-
ROC CodeRoc Bangalore
PAN
LEI Number
Active Compliance-

Financial Performance of Steth Pharmaceuticals Llp

Revenue Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▲ 38.3% Growth (3 Year) ▼ -9.9%
Profit/Loss Over The Year
2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
Growth (7 Year) ▼ 65.1% Growth (3 Year) ▼ 60.7%
Values are in Mixed (K, L, Cr)
Metrics FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Revenue 2,20,083.04 cr2,35,431.21 cr2,51,890.00 cr2,18,400.00 cr1,95,200.00 cr1,72,000.00 cr1,59,000.00 cr
Profit/Loss 13,969.70 cr 4,810.00 cr 12,200.00 cr 9,100.00 cr -8,200.00 cr 3,200.00 cr 5,100.00 cr
Cash & Bank Balance 38,200.00 cr35,100.00 cr32,000.00 cr28,500.00 cr25,200.00 cr22,000.00 cr19,800.00 cr
Net Worth 1,26,731.94 cr1,37,500.00 cr1,40,200.00 cr1,28,000.00 cr1,15,000.00 cr1,02,000.00 cr95,000.00 cr
EBITDA 27,865.49 cr29,800.00 cr30,200.00 cr27,000.00 cr24,500.00 cr22,000.00 cr20,100.00 cr

Financial Ratios

Revenue P/L EBITDA

Values in Crores (Cr) - illustrative trend

FY 2021 - FY 2025
Key Insights (FY 2025)
Revenue2,20,083.04 cr ▼ 6.5%
Profit/Loss13,969.70 cr ▲ 190.6%
EBITDA27,865.49 cr
Net Profit Margin10.54%
Debt/Equity0.47
Current Ratio0.88
Return on Equity12.3%
Ratio FY 2025FY 2024FY 2023FY 2022FY 2021
Net Profit Margin10.543.202.101.800.50
Debt to EBITDA2.141.901.701.501.20
Interest Coverage Ratio0.470.500.450.400.35
Debt to Equity0.880.900.850.800.75
Return on Equity12.103.002.001.500.20
Current Ratio1.201.151.101.050.99
Quick Ratio0.950.920.880.850.80
EBITDA Margin12.0010.008.007.005.00
Return on Capital Employed8.002.001.000.200.00
Earning Per Share4.000.000.000.000.00

LLP Contribution

Contribution Pattern (FY 2025)
  • Promoters 33.19%
  • DII 23.22%
  • FII 18.28%
  • Public 22.89%
  • Others 2.42%
Contribution Pattern over the Year
Category 20252024202320222021
Promoters33.19%33.50%33.80%34.00%34.41%
DII23.22%22.90%22.50%22.10%21.80%
FII18.28%18.00%17.60%17.20%16.90%
Public22.89%23.10%23.50%24.00%24.20%
Others2.42%2.50%2.60%2.70%2.69%

EPFO Establishments (1)

MRNOI0019835000 Closed/All Member Excluded
StatusCode No Allotted Was Before Online Registration Started.
ActivityPaper
StateUttar Pradesh
Coverage07-JUN-1995

Current Partners (2)

J
Designated Partner | Since 2016-03-22
R
Designated Partner | Since 2016-03-22

Flagged By Authority

Regulatory and exchange flags (preview)

Frequently Asked Questions about Steth Pharmaceuticals Llp
What is LLPIN/FCRN number of Steth Pharmaceuticals Llp?
The Limited Liability Partnership Identification Number (LLPIN) for Steth Pharmaceuticals Llp is AAG-0212.
When was Steth Pharmaceuticals Llp incorporated?
Steth Pharmaceuticals Llp was incorporated 10 years 1 month ago on 22 Mar 2016.
Who are the current designated partners and partners of Steth Pharmaceuticals Llp?
Currently 2 partners are associated with Steth Pharmaceuticals Llp: Jayashree, Rajesh Kodanda Ramu.
  • Jayashree
  • Rajesh Kodanda Ramu
What is the registered address of Steth Pharmaceuticals Llp?
As per Ministry of Corporate Affairs (MCA), the registered address of Steth Pharmaceuticals Llp is No.2397/15, 18Th Main,, Kumaraswamy Layout 2Nd Stage,, Bangalore South, Karnataka, 560078, India.
What is the ROC code of Steth Pharmaceuticals Llp?
Steth Pharmaceuticals Llp ROC code is Roc Bangalore.
What is the company classification of Steth Pharmaceuticals Llp?
Steth Pharmaceuticals Llp is classified as Limited Liability Partnership.
What is the current status of Steth Pharmaceuticals Llp?
Steth Pharmaceuticals Llp is currently Active and registered in Bangalore South, Karnataka, India.
What industry or business activity is Steth Pharmaceuticals Llp associated with?
Steth Pharmaceuticals Llp lists activity aligned with: Pharma - Drug Formulation & Development. See the Overview and Competition sections for fuller industry context.
Does Steth Pharmaceuticals Llp have GST registrations on file?
Steth Pharmaceuticals Llp shows 1 active GST registration signal(s) in compliance overview data. Open the Compliance tab for GSTIN and filing context when your plan allows.
What is the turnover or revenue of Steth Pharmaceuticals Llp?
Turnover and revenue appear in filed financial statements when available. Open the Financial tab on this profile for revenue, profit or loss, balance sheet metrics, and related MCA filings - not headline estimates.
How can I get the financial details of Steth Pharmaceuticals Llp?
You can view revenue, profit or loss, balance sheet metrics, and related filings on the Financial tab of this company profile.